NemerPharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

NemerPharma General Information

Description

Manufacturer of medicines designed for the treatment of neuropathic and cancer-related pain. The company's products use an alternative of TTX as a pharmaceutical ingredient, enabling cancer patients to reduce their medical bills.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Erik Dahlbergsgatan 11A
  • 411 26 Gothenburg
  • Sweden
+46 031-786 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NemerPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 08-Oct-2010 Completed Startup
To view NemerPharma’s complete valuation and funding history, request access »

NemerPharma FAQs

  • When was NemerPharma founded?

    NemerPharma was founded in 2008.

  • Where is NemerPharma headquartered?

    NemerPharma is headquartered in Gothenburg, Sweden.

  • What industry is NemerPharma in?

    NemerPharma’s primary industry is Drug Discovery.

  • Is NemerPharma a private or public company?

    NemerPharma is a Private company.

  • What is NemerPharma’s current revenue?

    The current revenue for NemerPharma is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »